A CMR prospective survey on heart iron and function in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy

25 May 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Quick Fire abstract session 6 Cardiac Magnetic Resonance EACVI Premium Access EuroCMR 2017

ESC 365 is supported by

ESC 365 is supported by